The first-ever transplantation of a microchip into the human brain has begun

Science continues to evolve and Synchron scientists have surpassed their competitor Neuralink! Indeed, Synchron will transplant the brain of its first patient. The first in a long series? We explain to you!

The invasion of fleas into the brain begins …

It’s a dream come true for technology companies. Indeed, they are motivated by economic reasons to push science even further, even if it may be dangerous for guinea pigs… In any case, even if some scientists are skeptical and even worried, these companies are ready for anything. Bloomberg shared an article last Wednesday that we won’t soon forget. Synchron, Neuralink’s direct neural interface competitor, is getting ahead of it and will try to transplant its first human patient. Elon Musk, owner of Neuralink, should be happy…

These “brain-computer interfaces” are chips that are placed in the brain. Initially, these chips were intended to treat people suffering from paralysis, such as those suffering from paralysis of the lower extremities. For example, they artificially affect the brain to make it move. Something like a superbrain or supermind. Clinical trials will begin on six patients who are severely paralyzed. For reasons of confidentiality, the identities of these patients are not disclosed and their testimonies are not made public. We know for sure that some of the trials will take place in New York, at Mount Sinai Hospital between Manhattan and Harlem, while others will be split between New York and Pittsburgh.

A super-intelligent brain awaits you…

The New York-based company was founded in 2016 and doesn’t take the same approach as Neuralink. Instead of a device with microwires connected directly to neurons, Synchron prefers to pass through blood vessels. In July 2021, Synchron received US FDA (Federal Drug Administration) approval to conduct human clinical trials.

Upon completion of these trials, if the results are positive, US authorities will give Synchron their consent to conduct these trials on a large number of patients. “It will probably be several years before the Stentrode goes on sale,” the author of the Bloomberg article explained. On the part of Neuralink and Elon Musk, delays are increasing. But the company did not say its last word. For example, Elon Musk raised much more funds than his competitor. Indeed, Neuralink raised $200 million a year ago, and Synchron has raised $70 million since its inception. This leaves great promise for Neuralink.

Technological breakthrough for medical purposes… bye!

Elon Musk intends to communicate with the brain using these super-intelligent chips. Indeed, one of his ambitions, for example, is for the brain to remotely control a computer without clicking, without speaking, or even moving his eyes … In other words, thought control. A year ago, in April, Neuralink shared a video of a monkey playing ping-pong on a computer with this system. “I think that the brain-computer interface could be very useful for medical purposes (if clinically proven to be useful). But it’s also a powerful technology, and I think non-medical use should be regulated before anything goes wrong,” explained scientist Jane Manchun Wong in August 2020.

Why is Neuralink in trouble?

Neuralink has management problems. Last February, Presse-citron published an article titled “Puzzle in Neuralink”. We were able to uncover a lot of internal problems of the company, because of which it also lost millions. Former employees admitted that there was staff turnover and that recruitment was difficult. Indeed, the working conditions and the pressure of goals on a very tight schedule daunted most of the best engineers. Employees aside, even co-founder Max Hodak left the company in May 2021 to move on to rival Synchron! We will keep you posted when this happens in France!

Back to top button